(3R,5R)-3,5-Dihydroxy-7-((1S,2S,8S,8aR)-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-6-oxo-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid

Catalog No. :
ACKKOK910
CAS No. :
201423-59-8
Molecular Formula :
C23H34O7
Molecular Weight :
422.52

IUPAC Name:(3R,5R)-3,5-dihydroxy-7-((1S,2S,8S,8aR)-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-6-oxo-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid

(3R,5R)-3,5-Dihydroxy-7-((1S,2S,8S,8aR)-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-6-oxo-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,5R)-3,5-Dihydroxy-7-((1S,2S,8S,8aR)-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-6-oxo-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid
IUPAC Name(3R,5R)-3,5-dihydroxy-7-((1S,2S,8S,8aR)-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-6-oxo-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid
Molecular FormulaC23H34O7
Molecular Weight422.52
SMILESO=C(O)C[C@H](O)C[C@H](O)CC[C@H]1[C@@H](C)C=CC2=CC(C[C@H](OC([C@@H](C)CC)=O)[C@]12[H])=O
InChI KeyQLADBRMJZFWJSF-YOMJSHEQSA-N
SynonymPravastatin 6'-Ketone SodiuM Salt;Pravastatin 6-Oxo Impurity;1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-β,δ-dihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-6-oxo-, (βR,δR,1S,2S,8S,8aR)-;Pravastatin 6''-Ketone
CAS No.201423-59-8

Synthetic Route by SureRoute

1. ACKKOK910 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKKOK910 route product structure diagram
    ACKKOK910201423-59-8
Inquiry

2. ACKKOK910 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKKOK910 route product structure diagram
    ACKKOK910201423-59-8
Inquiry

Comments (0)